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Can dynamic multidetector computerized tomography detect
renal cell carcinoma subtypes?
Ayhan DİRİM1, Nihal TUTAR2, Levent PEŞKİRCİOĞLU1, Hüseyin ÇELİK1, Mehmet İlteriş TEKİN1,
Hakan ÖZKARDEŞ1
Aim: To evaluate the efficacy of the biphasic and triphasic dynamic multidedector computerized tomography (MDCT) in
the preoperative prediction of histological subtypes of renal cell carcinoma (RCC).
Materials and methods: The preoperative dynamic MDCT findings of 51 patients with renal mass who had undergone
nephrectomy were reviewed retrospectively. Twenty-five of the patients had biphasic (portal and excretory) and 26 had
triphasic (arterial, portal, and excretory) MDCT images. Tumor size, presence of calcification, tumor-aorta attenuation
values in all phases and homogeneicity of the tumor were noted for every patient. In heterogeneous tumors, the minimum
and maximum attenuation values were noted to determine the extent of heterogeneicity. These data were compared for
histopathological subtypes of the tumors.
Results: In 8 patients, calcifications were detected in the mass although there were no significant differences among tumor
subtypes with regard to the presence of calcification. In 33 patients the tumor was hypervascular with 24 clear type and clear
type RCC showed more prominent contrast enhancement than papillary RCC. The enhancement degree showed no
significant difference among other tumor subtypes. Moreover, when biphasic and triphasic computed tomography (CT)
findings were compared, the positive predictive value of triphasic CT in detecting hypervascular clear tumors was greater
(17/18; 94.4% versus 7/11; 63.6%).
Conclusion: The dynamic MDCT technique appears to be useful in preoperative evaluation of renal masses suspected of
being malignant and may also provide information about the histopathological subtype of RCC.
Key words: Multidedector computerized tomography, renal cell carcinoma, renal cancer subtypes

Dinamik multidedektör komputerize tomografi renal hücreli kanser subtiplerini
belirleyebilir mi?
Amaç: Renal hücreli kanser (RHK) histolojik subtiplerinin preoperatif tahmininde bifazik ve trifazik dinamik multidedektör
komputerize (bilgisayarlı) tomografinin (DMKT) etkinliğini değerlendirmek.
Yöntem ve gereç: Renal kitle nedeniyle nefrektomi yapılan 51 hastanın preoperatif dinamik MDKT bulguları retrospektif
olarak değerlendirildi. Yirmibeş olguda bifazik (portal ve ekskretuar), 26 olguda ise trifazik (arteryal, portal, ve ekskretuar)
MDKT görüntüleri elde edildi. Her olgunun tümör çapı, kalsifikasyon varlığı, her fazdaki tümör-aorta atenüasyon değerleri
ve tümör homojenitesi belirlendi. Heterojen tümörlerde heterojenite farkı/derecesini belirlemek için minimum ve
maksimum atenüasyon değerleri not edildi. Bu veriler tümörün histopatolojik subtipleriyle karşılaştırıldı.
Bulgular: Sekiz olguda kitlede kalsifikasyon saptandı ancak kalsifikasyon varlığı ile tümör subtipleri arasında bir farklılık
sözkonusu değildi. Otuzüç olguda tümör hipervaskülerdi. Bu olguların 24’ü şeffaf hücreli tipteydi ve şeffaf hücreli tip papiller
tipe göre daha belirgin kontrastlanma göstermekteydi. Diğer tümör tipleri arasında kontrastlanma derecesi açısından
farklılık izlenmedi. Yine bifazik ve trifazik tomografi bulguları karşılaştırıldığında trifazik tomografinin hipervasküler şeffaf
hücreli tümörü saptamadaki pozitif prediktif değeri bifazikten yüksekti (17/18; % 94,4’e karşın 7/11; % 63,6).
Sonuç: Dinamik MDKT tekniği malignite şüphesi olan renal kitlelerin preoperatif değerlendirmesinde yararlı olması
yanında RHK’in histopatolojik subtiplerinin belirlenebilmesi konusunda da bilgi verebilir.
Anahtar sözcükler: Multidedektör komputerize tomografi, renal hücreli karsinom, renal kanser subtipleri
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Introduction
Computed tomography (CT) remains to be the
gold standard modality for diagnosing and staging
renal neoplasms, and the wide use of CT for
abdominal imaging has led to earlier detection of
many small renal neoplasms (1-3). Preoperative
estimation of the tumor subtype may help to choose
the appropriate treatment modality and provide
information for predicting postoperative prognosis.
Papillary RCC are associated with a better prognosis
than other cell types at a similar stage, but papillary
renal cancers are more frequently multiple, bilateral,
and can be hereditary (4, 5). These characteristics of
papillary RCC may let the physician to plan a partial
nephrectomy in selected patients if it can be detected
preoperatively by MDCT.
Materials and methods
Patients
The dynamic MDCT findings of 51 patients who
had undergone radical (n = 41) or partial (n = 10)
nephrectomy between May 2005 and October 2007
because of renal mass were reviewed retrospectively.
Twenty-five of the patients had biphasic (portal and
excretory) and 26 had triphasic (arterial, portal, and
excretory) MDCT images. Tumor size, presence of
calcification and necrosis, and tumor–aorta
attenuation values in all phases and homogeneicity of
the tumor were recorded for every patient. In
heterogeneous tumors the minimum and maximum
attenuation values were recorded to determine the
extent of heterogeneicity. These data were compared
for histopathological subtypes of tumors.
CT examination
Triphasic renal CT was performed on either a
Somatom Plus 4 (Siemens Medical Systems, Germany)
or a Volume Zoom (Siemens Medical Systems,
Germany) 16 detector scanner. Oral contrast agent was
administered to all patients. Each patient was scanned
before intravenous contrast administration for
precontrast imaging. Then arterial, portal, and excretory
phase images were obtained. Delay time was 20 seconds
for the arterial phase, 60 seconds for the portal phase,
and 5 min for the excretory phase images. Slice
thickness was 5 mm for all phases. Nonionic contrast
media (150 mL) was injected using a mechanical
injector at a rate of 4.5 mL/sec. Axial CT images were
32

reconstructed after the scanning had finished in axial
and coronal planes using the multiplanar reconstruction
(MPR) technique in each patient.
Statistical analysis
The Kruskal Wallis analysis of variance and chisquare tests were used as statistical methods. A P
value of 0.05 was accepted as cut-off for statistical
significance. The analyses were done using SPSS 11.0
for Windows.
Results
Patients
There were 22 female and 29 male patients with a
mean age of 59.8 years (range: 34-80). The male-tofemale ratio was 1.07/1 in clear cell RCC, 5.5/1 in
papillary RCC, and 1/1 in chromophobe cell RCC.
While 2 patients with oncocytoma and 2 patients with
angiomyolipoma (AML) were females, the patient
with leiomyosarcoma was male. Neither age nor sex
significantly differed among tumor subtypes (P =
0.771, P = 0.131, respectively).
Pathological findings
The histopathologically detected tumor subtypes
were noted as 29 clear cell RCC; 13 papillary RCC; 4
chromophobe cell RCC; 2 oncocytomas; 2
angiomyolipomas; and 1 leiomyosarcoma. There was
no significant difference among tumor subtypes in
terms of tumor grades (P = 0.952).
CT findings
The mean tumor size was 5.06 cm (range: 1-19).
Distribution of tumor sizes according to histological
subtypes is shown in Table 1. There was no significant
difference between tumor subtypes with respect to
tumor size (P = 0.341)
Table 1. The distribution of tumor size according to histological
subtypes.

Clear cell RCC
Papillary RCC
Chromophobe cell RCC
Oncocytoma
Angiomyolipoma
Leiomyosarcoma

n

Mean tumor size
(range) (cm)

29
13
4
2
2
1

4.9 (1.8-12)
4.9 (1.2-19)
8.6 (2-15)
3.1 (1.3-5)
5.9 (1.8-10)
10
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Tumor densities during precontrast, arterial,
portal, and late phases (hypodense, isodense, and
hyperdense) did not show any significant difference
according to tumor subtypes (P = 0.560, P = 0.289, P
= 0.459, and P = 0.157, respectively).

in each phase (Table 3).

Necrosis was observed in 22 patients (centrally in
17, peripherally in 1, and both centrally and
peripherally in 4 patients). Presence of necrosis did
not differ in terms of tumor subtypes (P = 0.369).

In 33 patients, the tumor was hypervascular and
clear type RCC (Figure 1) showed more prominent
contrast enhancement than papillary RCC (Figure 2).
The mean maximum enhancement was 104.6 ± 48.5
Hounsfield Units [HU] (30-210 HU) in clear cell
tumors whereas it remained at 64.6 ± 40.8 HU (25183 HU) in papillary RCC (P = 0.014). The
enhancement degree showed no significant difference
among other tumor subtypes (P > 0.05). The
histological subtypes of 33 hypervascular masses on
CT were clear cell RCC in 24 patients; chromophobe
in 3, papillary in 2, oncocytoma in 2, AML in 1, and
leiomyosarcoma in 1 case.

On MDCT scanning, homogeneus contrast
enhancement was detected in 19 cases but there was
no difference between subtypes according to the
contrast enhancement pattern (P = 0.093) (Table 2).
In heterogeneous tumors, the degree of
heterogeneicity did not differ between tumor subtypes

When the biphasic and triphasic CT findings were
compared, the positive predictive value of triphasic
CT in detecting hypervascular clear tumors was
greater (17/18; 94.4% versus 7/11; 63.6%). The
attenuation and enhancement values of each mass are
shown in Table 4.

Calcification was detected in 8 cases. These
calcifications were located centrally in 4, peripherally
in 2, and both centrally and peripherally in 2 patients.
Presence of calcification did not show any significant
difference in terms of tumor subtypes (P = 0.263).

Table 2. The enhancement patterns according to histopathological subtypes.*
Histopathological Subtypes
Enhancement
Pattern

Homogeneous
Heterogeneous
Total
Homogeneous
Heterogeneous
Total

Tumor
size (cm)

≤5

>5

Clear
(n = 29)

Papillary
(n =13)

Chromophobe
(n = 4)

Oncocytoma
(n = 2)

AML
(n = 2)

7
11
18
2
9
11

6
2
8
1
4
5

1
0
1
0
3
3

1
1
2
0
0
0

0
1
1
1
0
1

*The only case of leiomyosarcoma (heterogeneous) is not shown.

AML = Angiomyolipoma

Table 3. The degree of heterogeneicity of RCC subtypes according to CT phases.
Degree of Heterogeneicity
Clear cell RCC
biphasic
triphasic
(n = 6)
(n = 14)
Precontrast
Arterial
Portal
Excretory

19.1 ± 18.5
99.8 ± 38.5
44.6 ± 5

16.4 ± 7.9
65.7 ± 37.8
90.3 ± 42
50 ± 22.9

Papillary RCC
biphasic
triphasic
(n = 4)
(n = 2)
22.5 ± 12
46.2 ± 24.5
34 ± 22.6

11.5 ± 4.9
25.5 ± 19
110 ± 70.7
32.6 ± 4.9

Chromophobe RCC
biphasic
triphasic
(n = 1)
(n = 2)
7
70
37

18.9 ± 12.7
24.7 ± 14.1
76.4 ± 45.2
56.5 ± 31.6
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a

b

c

d

Figure 1. The preoperative triphasic MDCT images of a renal mass located anteriorly at the middle portion of the right kidney. Minimally
hypodense region compared to parenchyma during precontrast scan (a); heterogenous contrast enhancement more prominent
peripherally during arterial phase (b); contrast material wash-out causing difficulty in differring the mass from normal renal
parenchyma during portal (c), and excretory (d) phases. Histopathological examination revealed clear cell carcinoma.

Discussion
Classification of RCC subtypes has become
popular recently since the subtypes have a clear
impact on prognosis (6,7). The histological subtypes
of renal cell carcinoma can be classified as clear cell,
papillary, chromophobe, collecting duct, and
unclassified carcinomas (8,9). The conventional clear
cell RCC is the most common subtype, accounting for
approximately 70% of renal cell carcinomas. The
overall 5-year survival rate of patients with RCC
ranges from 55% to 60% (8,10,11). Clear cell RCC has
lower overall 5-year survival rate compared to
papillary and chromophobe tumors at the same stage
(7,10).
34

The enhancement patterns of renal masses are
important and provide invaluable data about tumor
vascularity. Dynamic thin-section CT with
administration of contrast medium by bolus
peripheral injection has been reported to be superior
to conventional enhanced CT in evaluating tumor
vascularity (12,13). The enhancement property is the
mainstay of predictions about tumor histology.
Preoperative estimation of histology may also provide
advantages besides prediction of prognosis as to
decide a survey for metastases, planning the operative
approach, and also discriminating benign lesions as
oncocytoma, angiomyolipoma, complicated cysts, or
benign mesenchymal tumors (6, 14). The prediction
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Figure 2. The preoperative triphasic MDCT images of a renal mass located anteriorly at the lower pole of right kidney. Isodence
appearance during precontrast scan (a); a hypodense mass with a poor contrast enhancement during arterial (b); portal (c);
and excretory (d) phases. Histopathological examination revealed papillary RCC.

of the subtype of RCC may influence the degree of
preoperative evaluation. For example, a patient with a
subtype of RCC that tends to not metastasize, such as
chromophobe renal carcinoma, may not need to
undergo a complex matastasis survey (6). For patients
with surgically treatable RCC, radical nephrectomy
has been indicated as the standard treatment. In spite
of improved surgical techniques, postoperative
mortality and morbidity remain high. With this point
of view, precise preoperative identification of the
subtype of RCC may be helpful in determining the
appropriate extent of surgery. For example, an
unnecessarily wide resection may be avoided in

patients with a subtype that is likely to recur or
metastasize, thereby reducing postoperative
morbidity and mortality (6). Furthermore, a papillary
RCC may be preferentially treated with nephron
sparing surgery because the propensity of the disease
is bilateral and diagnosed at an earlier stage. In
addition, because of the possibility of synchronous or
metachronous lesions, patients with papillary RCC
should be followed up more closely after undergoing
partial nephrectomy (15).
In terms of CT findings, clear cell RCC is often a
hypervascular tumor, which tends to be
heteregeneous when larger (14). It is demonstrated
35
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Table 4. The attenuation and enhancement levels in biphasic* and triphasic CT phases in terms of histopathological subtypes.

Biphasic Dynamic CT Phase

Histopathological Subtypes
Clear cell RCC
(n = 11)

Papillary RCC
(n = 10)

Chromophobe cell RCC
(n = 1)

Oncocytoma
(n = 1)

AML
(n = 1)

36 ± 15

28.4 ± 15.4

31

44

25

Portal
Attenuation
Enhancement

136.4 ± 63.2
100.7 ± 62.9

71.4 ± 29.6
43.3 ± 22.5

95
64

205
106

113
90

Excretory
Attenuation
Enhancement

68.8 ± 28.6
37.6 ± 28.2

60.5 ± 20.5
42.8 ± 27.9

68
57

113
55

57
32

Clear cell RCC
(n = 18)

Papillary RCC
(n = 3)

Chromophobe cell RCC
(n = 3)

Oncocytoma
(n = 1)

AML
(n = 1)

34.2 ± 14

48.5 ± 37

32.8 ± 21.2

24

31

Arterial
Attenuation
Enhancement

97.5 ± 43.8
64.8 ± 40.4

68.2 ± 43.9
19.8 ± 7.5

44.1 ± 10.5
25.5 ± 25

25
1

33
2

Portal
Attenuation
Enhancement

130.9 ± 33.5
98.7 ± 37.2

128.8 ± 56.2
94.2 ± 73.7

85.8 ± 20.5
70 ± 45.3

210
185

68
37

Excretory
Attenuation
Enhancement

87.5 ± 25.9
55.7 ± 25.6

86.7 ± 25.1
44.7 ± 14.1

57.8 ± 21.1
33.1 ± 11.6

63
40

114
83

Precontrast
Attenuation

Triphasic Dynamic CT Phase

Precontrast
Attenuation

*The only case of leiomyosarcoma (heterogeneous) is not shown.

AML = Angiomyolipoma

that conventional RCC exhibits stronger
enhancement than nonconventional RCC (6, 14, 16),
which is attributed to its rich vascular network and
alveolar architecture (7, 14). Twenty four of our 29
patients with clear cell carcinoma showed
hypervascular CT images (P = 0.000). In our series
clear cell RCC showed stronger enchancement than
only papillary RCC among other subtypes. It was
remarkable that the positive predictive value of
triphasic CT in detecting hypervascular clear tumors
was greater than that of biphasic CT. The lesions of
clear cell RCC were predominantly heterogeneous
(20/29 cases, P = 0.041). The lesions over 5 cm tended
to be more heterogeneous but this correlation was not
statistically significant. When the degree of
heterogeneicity is evaluated in heterogeneous tumors,

no statistically significant difference was observed
according to the CT technique (biphasic vs. triphasic)
and phases (precontrast, arterial, portal, and
excretory) or tumor subtypes.
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Papillary renal cell carcinoma is typically a
hypovascular and homogeneous tumor on CT. It usually
appears in low stage and grade at presentation and tends
to be multifocal or bilateral (1,4,15,17-20). In our cases
11 of 13 papillary RCC were hypovascular (P = 0.013)
and 7 of them were homogeneous (P = 0.782). No
significant correlation was observed with the tumor
grade. It has been reported that calcifications are more
frequently observed in papillary renal cell carcinoma
(6,16). Our findings supported this finding since 4 of the
8 calcific lesions were in the papillary group.
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Kondo et al. reported 2 distinct patterns of
chromophobe cell RCC. Pattern 1 was characterized
by a tumor enhancement with low density to
isodensity compared to the renal medulla in the
corticomedullary phase during dynamic CT scan
(21). The tumors of this group were isodense on
unenhanced CT scans with a lobulated appearance
and a spoke wheel-like enhancement in some cases.
Pattern 2 was characterized by a hyperdense
enhancement in the corticomedullary phase. The
tumors of this group were iso- to high-density without
homogeneicity on unenhanced CT scans with a
lobulated appearance in selected cases and no spoke
wheel-like enhancement. None of our 4 chromophobe
patients showed a spoke wheel-like enhancement.
Only 1 patient out of 3 with lobulated appearance who
were in concordance with pattern 1 had
homogeneicity. The remaining one patient had a
hyperdense appearance in precontrast and arterial
sections without having the homogeneicity described
in pattern 2. All patients, except one with the
characteristics of pattern 1, were hypervascular.
It is well known that oncocytomas are
phenotypically closely related to chromophobe cell
RCC, which makes it difficult to differentiate from
RCC (22-24). Both oncocytoma cases in our group
were hypervascular, without having calcifications and
lobulations. These lesions were isodense in
precontrast sections whereas hyperdense in portal
phases. Only 1 of these 2 oncocytoma lesions was
homogeneous.

Two of our cases were angiomyolipomas. Both of
these lesions were isodense in precontrast and portal
sections. These lesions also had no calcifications and
lobulations. One of these lesions was homogeneous
and the other one was hypervascular.
Fujimoto et al. and Wildberger et al. proposed that
stronger enhancement is an important finding to
differentiate conventional RCC from other subtypes
(14, 16). Our findings support this statement only for
papillary RCCs. Besides, we conclude that
combination of other diagnostic parameters should
be used in order to estimate the tumor subtypes just as
suggested by Kim JK et al. (6). For example, a
hypervascular heterogeneous lesion without any
calcification may be estimated as a clear cell RCC. On
the other hand, a hypovascular lesion with
calcification more prominently may suggest papillary
RCC.
Conclusion
CT scanning appears as a very helpful imaging
modality in the diagnosis of renal cell carcinoma and
discrimination of histological subtypes. Dynamic
workup with triphasic imaging emphasizes the
importance of a meticulous technique in CT
scanning.
Although
hypervascularity
and
calcifications seem to be important parameters in
suggesting histological RCC subtypes, the low
incidences of certain types of tumors hinder the
explanation of the real predictive power of CT
findings.
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